✳flâneur — a map of the web's best reading

Biomarkers for Parkinson’s Disease: How Good Are They? | Neuroscience Bulletin

link.springer.com · 323 words · saved by 1 readers

Parkinson’s disease (PD) is a complex neurodegenerative disorder with no cure in sight. Clinical challenges of the disease include the inability to make a definitive diagnosis at the early stages and difficulties in predicting the disease progression. The unmet demand to identify reliable biomarkers for early diagnosis and management of the disease course of PD has attracted a lot of attention. However, only a few reported candidate biomarkers have been tried in clinical practice at the present time. Studies on PD biomarkers have often overemphasized the discovery of novel identity, whereas efforts to further evaluate such candidates are rare. Therefore, we update the new development of biomarker discovery in PD and discuss the standard process in the evaluation and assessment of the diagnostic or prognostic value of the identified potential PD biomarkers in this review article. Recent developments in combined biomarkers and the current status of clinical trials of biomarkers as outcom

Biomarkers for Parkinson’s Disease: How Good Are They? Review Published: 23 October 2019 Volume 36 , pages 183–194 ( 2020 ) Cite this article Save article View saved research Neuroscience Bulletin Aims and scope Submit manuscript Abstract Parkinson’s disease (PD) is a complex neurodegenerative disorder with no cure in sight. Clinical challenges of the disease include the inability to make a definitive diagnosis at the early stages and difficulties in predicting the disease progression. The unmet demand to identify reliable biomarkers for early diagnosis and management of the disease course of

Explore this link on the map →

related reading